VF
CSBR icon

Virtu Financial’s Champions Oncology CSBR Stock Holding History

Virtu Financial’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,051
Closed -$95K – 1475
2024
Q4 		$95K Buy
+11,051
New +$55.6K 0.01% 1032
2018
Q4 		– Sell
-36,751
Closed -$642K – 1619
2018
Q3 		$642K Buy
+36,751
New +$327K 0.04% 495

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's CSBR Position: Q1 2025 in Review

Virtu Financial sold out of Champions Oncology (CSBR) in Q1 2025, closing a stake of 11,051 shares — an estimated $95K sold.

Virtu Financial first reported a position in CSBR in Q3 2018 and held it in 2 quarters. The position peaked at $642K in Q3 2018. 34 funds tracked by Wall St. Rank hold CSBR as of Q1 2025.

  • Virtu Financial reported no remaining Champions Oncology position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 11,051 Champions Oncology shares in Q1 2025, an estimated $95K.
  • Virtu Financial first reported a position in Champions Oncology in Q3 2018 and held it in 2 quarters.
  • Virtu Financial's Champions Oncology position peaked at $642K in Q3 2018.
  • 34 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.